Jan 25 (Reuters) - Biotalys NV BTLS.BR :
* BIOTALYS ACHIEVES BREAKTHROUGH IN PROTEIN EXPRESSION
INCREASING
COMMERCIAL POTENTIAL FOR ITS FIRST BIOFUNGICIDE EVOCA
* NEXT GENERATION OF EVOCA PRODUCTS PROVIDES COMMERCIAL
POTENTIAL
AT 2026 HORIZON
* REGISTRATION APPROVAL FIRST IN UNITED STATES BY
ENVIRONMENTAL
PROTECTION AGENCY (EPA) WHICH IS EXPECTED IN SECOND HALF OF 2022
Source text for Eikon: ID:nGNEKDZzc
Further company coverage: BTLS.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))